Finding effective treatments and a cure for Alzheimer’s disease is elusive. While most of what we hear about the disease is depressing, we may be on the threshold of some exciting discoveries concerning prevention. Washington University’s School of Medicine is in the middle of this new research and this hour, host Don Marsh is joined by Dr. John Morris, Director of Washington University’s Alzheimer’s Research Center, to talk about clinical trials aimed at preventing Alzheimer’s disease.
There's a local connection to this development - The Genome Institute at Washington University School of Medicine says they "played an important role in this project by generating genome sequence data." Learn more via the link.
Scientists unveiled the results of a massive international project Wednesday that they say debunks the notion that most of our genetic code is made up of so-called junk DNA. The ENCODE project, which involved hundreds of researchers in dozens of labs, also produced what some scientists are saying is like Google Maps for the human genome.
It will take the rover seven minutes to get from the Mars atmosphere to the planet's surface. But because it takes about twice that long for signals to travel from Mars to Earth, scientists won't know anything about the landing until after it's already over.
Pediatric leukemia is a cancer of the blood and bone marrow. There are about 3,000 new cases in the United States every year, typically in children between the ages of four and six.
With treatment, about three-quarters of affected children are able to beat the disease.
But for those with what’s known as “high risk” leukemia, the odds of survival are much worse.
Washington University pediatric oncologist Dr. Todd Druley has been trying to use genetics to understand why some leukemia is so hard to treat. He spoke with St. Louis Public Radio's Véronique LaCapra.